Levy V, Lengline E, Chevret S. When evaluating targeted therapies in chronic lymphocytic leukemia, the absolute measure of treatment effect should be preferred. Leuk Lymphoma 2026 Mar 24:1-10. doi: 10.1080/10428194.2026.2647950.
PMID: 41874213